$1.1B
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | UNH Unitedhealth Group Inc | 93,600 | +105.7% | $39M | 3.7% |
| 2 | CVS Cvs Health Corp | 279,374 | −17.0% | $29M | 2.7% |
| 3 | AZN Astrazeneca Plc | 151,500 | — | $28M | 2.7% |
| 4 | MRK Merck & Co Inc | 213,500 | — | $27M | 2.6% |
| 5 | LLY Eli Lilly & Co | 22,315 | −33.8% | $27M | 2.5% |
| 6 | ABBV Abbvie Inc | 96,775 | +35.2% | $24M | 2.3% |
| 7 | ALHC Alignment Healthcare Inc | 997,083 | −5.4% | $24M | 2.2% |
| 8 | EW Edwards Lifesciences Corp | 260,000 | +59.5% | $24M | 2.2% |
| 9 | GILD Gilead Sciences Inc | 178,250 | +6.3% | $23M | 2.1% |
| 10 | JAZZ Jazz Pharmaceuticals Plc | 87,440 | +15.2% | $21M | 2.0% |
| 11 | BIIB Biogen Inc | 94,850 | −13.1% | $20M | 1.9% |
| 12 | SYK Stryker Corporation | 65,000 | +36.0% | $20M | 1.9% |
| 13 | BSX Boston Scientific Corp | 450,500 | −27.9% | $19M | 1.8% |
| 14 | JNJ Johnson & Johnson | 72,500 | — | $18M | 1.7% |
| 15 | GH Guardant Health Inc | 115,000 | −20.7% | $17M | 1.6% |
| 16 | REGN Regeneron Pharmaceuticals | 27,390 | −43.1% | $17M | 1.6% |
| 17 | GKOS Glaukos Corp | 119,000 | +41.7% | $17M | 1.6% |
| 18 | BMRN Biomarin Pharmaceutical Inc | 290,500 | +40.3% | $17M | 1.6% |
| 19 | NRIX Nurix Therapeutics Inc | 684,250 | +118.3% | $17M | 1.6% |
| 20 | NTRA Natera Inc | 61,050 | +18.3% | $17M | 1.6% |
| 21 | MIRM Mirum Pharmaceuticals Inc | 139,205 | +50.3% | $16M | 1.5% |
| 22 | INSM Insmed Inc | 151,960 | −4.9% | $16M | 1.5% |
| 23 | THC Tenet Healthcare Corp | 85,200 | +57.8% | $16M | 1.5% |
| 24 | TMO Thermo Fisher Scientific Inc | 31,580 | −23.6% | $16M | 1.5% |
| 25 | CNC Centene Corp Del | 244,000 | — | $16M | 1.5% |
| 26 | AXSM Axsome Therapeutics Inc. | 63,050 | −1.2% | $15M | 1.5% |
| 27 | DANAHER CORP DEL Danaher Corp Del | 80,252 | +344.6% | $15M | 1.4% |
| 28 | VERTEX PHARMACEUTICALS INC Vertex Pharmaceuticals Inc | 30,685 | −29.4% | $15M | 1.4% |
| 29 | AVR Anteris Technologies Global | 1.5M | +7.0% | $15M | 1.4% |
| 30 | NBIX Neurocrine Biosciences Inc | 85,841 | −14.9% | $14M | 1.4% |
| 31 | PNTG Pennant Group Inc | 371,471 | +34.9% | $14M | 1.3% |
| 32 | ISRG Intuitive Surgical Inc | 34,500 | −6.4% | $14M | 1.3% |
| 33 | ELV Elevance Health Inc Formerly | 34,900 | +8.0% | $13M | 1.3% |
| 34 | LIVN Livanova Plc | 164,000 | +5.8% | $13M | 1.3% |
| 35 | COR Cencora Inc | 46,778 | −10.7% | $13M | 1.2% |
| 36 | CHARLES RIV LABS INTL INC Charles Riv Labs Intl Inc | 57,200 | +120.0% | $13M | 1.2% |
| 37 | IDYA Ideaya Biosciences Inc | 343,800 | +34.6% | $13M | 1.2% |
| 38 | MCK Mckesson Corp | 16,550 | −1.8% | $13M | 1.2% |
| 39 | SNDX Syndax Pharmaceuticals Inc | 560,250 | +47.7% | $12M | 1.2% |
| 40 | BRIGHTSPRING HEALTH SVCS INC Brightspring Health Svcs Inc | 165,896 | +231.8% | $12M | 1.1% |
| 41 | MDT Medtronic Plc | 145,000 | +61.1% | $11M | 1.1% |
| 42 | MLYS Mineralys Therapeutics Inc | 416,371 | +58.3% | $11M | 1.1% |
| 43 | OSCR Oscar Health Inc | 392,000 | −40.6% | $11M | 1.1% |
| 44 | RPRX Royalty Pharma Plc | 197,000 | −15.5% | $11M | 1.0% |
| 45 | DXCM Dexcom Inc | 160,000 | — | $11M | 1.0% |
| 46 | ALGN Align Technology Inc | 63,000 | +740.0% | $11M | 1.0% |
| 47 | SYRE Spyre Therapeutics Inc | 119,300 | — | $11M | 1.0% |
| 48 | RLAY Relay Therapeutics Inc | 566,000 | +57.2% | $11M | 1.0% |
| 49 | ARWR Arrowhead Pharmaceuticals In | 128,000 | −11.4% | $10M | 1.0% |
| 50 | A Agilent Technologies Inc | 75,000 | +200.0% | $10M | 0.9% |